359 related articles for article (PubMed ID: 9824312)
41. PTEN and Other PtdIns(3,4,5)P
Csolle MP; Ooms LM; Papa A; Mitchell CA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
[TBL] [Abstract][Full Text] [Related]
42. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.
Ooms LM; Horan KA; Rahman P; Seaton G; Gurung R; Kethesparan DS; Mitchell CA
Biochem J; 2009 Apr; 419(1):29-49. PubMed ID: 19272022
[TBL] [Abstract][Full Text] [Related]
43. SHIP, a new player in cytokine-induced signalling.
Liu L; Damen JE; Ware M; Hughes M; Krystal G
Leukemia; 1997 Feb; 11(2):181-4. PubMed ID: 9009077
[TBL] [Abstract][Full Text] [Related]
44. Evidence of SHIP2 Ser132 phosphorylation, its nuclear localization and stability.
Elong Edimo W; Derua R; Janssens V; Nakamura T; Vanderwinden JM; Waelkens E; Erneux C
Biochem J; 2011 Nov; 439(3):391-401. PubMed ID: 21770892
[TBL] [Abstract][Full Text] [Related]
45. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling.
Ishihara H; Sasaoka T; Hori H; Wada T; Hirai H; Haruta T; Langlois WJ; Kobayashi M
Biochem Biophys Res Commun; 1999 Jun; 260(1):265-72. PubMed ID: 10381377
[TBL] [Abstract][Full Text] [Related]
46. SHIPs ahoy.
Krystal G; Damen JE; Helgason CD; Huber M; Hughes MR; Kalesnikoff J; Lam V; Rosten P; Ware MD; Yew S; Humphries RK
Int J Biochem Cell Biol; 1999 Oct; 31(10):1007-10. PubMed ID: 10582334
[TBL] [Abstract][Full Text] [Related]
47. Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling.
Zwaenepoel K; Goris J; Erneux C; Parker PJ; Janssens V
FASEB J; 2010 Feb; 24(2):538-47. PubMed ID: 19825976
[TBL] [Abstract][Full Text] [Related]
48. The role of SHIP in cytokine-induced signaling.
Kalesnikoff J; Sly LM; Hughes MR; Büchse T; Rauh MJ; Cao LP; Lam V; Mui A; Huber M; Krystal G
Rev Physiol Biochem Pharmacol; 2003; 149():87-103. PubMed ID: 12692707
[TBL] [Abstract][Full Text] [Related]
49. Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2.
Bradshaw WJ; Kennedy EC; Moreira T; Smith LA; Chalk R; Katis VL; Benesch JLP; Brennan PE; Murphy EJ; Gileadi O
Structure; 2024 Apr; 32(4):453-466.e6. PubMed ID: 38309262
[TBL] [Abstract][Full Text] [Related]
50. Impact of Src homology 2-containing inositol 5'-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acids.
Murakami S; Sasaoka T; Wada T; Fukui K; Nagira K; Ishihara H; Usui I; Kobayashi M
Endocrinology; 2004 Jul; 145(7):3215-23. PubMed ID: 15044364
[TBL] [Abstract][Full Text] [Related]
51. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
[TBL] [Abstract][Full Text] [Related]
52. SHIP2 associates with intersectin and recruits it to the plasma membrane in response to EGF.
Xie J; Vandenbroere I; Pirson I
FEBS Lett; 2008 Sep; 582(20):3011-7. PubMed ID: 18692052
[TBL] [Abstract][Full Text] [Related]
53. A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery.
Mills SJ; Persson C; Cozier G; Thomas MP; Trésaugues L; Erneux C; Riley AM; Nordlund P; Potter BV
ACS Chem Biol; 2012 May; 7(5):822-8. PubMed ID: 22330088
[TBL] [Abstract][Full Text] [Related]
54. Src family tyrosine kinases regulate adhesion-dependent tyrosine phosphorylation of 5'-inositol phosphatase SHIP2 during cell attachment and spreading on collagen I.
Prasad N; Topping RS; Decker SJ
J Cell Sci; 2002 Oct; 115(Pt 19):3807-15. PubMed ID: 12235291
[TBL] [Abstract][Full Text] [Related]
55. Localization of mRNA for SHIP2, SH2 domain-containing inositol polyphosphate 5-phosphatase, in the brain of developing and mature rats.
Kudo M; Saito S; Owada Y; Suzaki H; Kondo H
Brain Res Mol Brain Res; 2000 Jan; 75(1):172-7. PubMed ID: 10648902
[TBL] [Abstract][Full Text] [Related]
56. Regulation of endogenous SH2 domain-containing inositol 5-phosphatase (SHIP2) in 3T3-L1 and human preadipocytes.
Gagnon A; Artemenko Y; Crapper T; Sorisky A
J Cell Physiol; 2003 Nov; 197(2):243-50. PubMed ID: 14502564
[TBL] [Abstract][Full Text] [Related]
57. SHIP2 controls PtdIns(3,4,5)P(3) levels and PKB activity in response to oxidative stress.
Zhang J; Liu Z; Rasschaert J; Blero D; Deneubourg L; Schurmans S; Erneux C; Pesesse X
Cell Signal; 2007 Oct; 19(10):2194-200. PubMed ID: 17643961
[TBL] [Abstract][Full Text] [Related]
58. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?
Astle MV; Horan KA; Ooms LM; Mitchell CA
Biochem Soc Symp; 2007; (74):161-81. PubMed ID: 17233589
[TBL] [Abstract][Full Text] [Related]
59. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
[TBL] [Abstract][Full Text] [Related]
60. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.
Suwa A; Yamamoto T; Sawada A; Minoura K; Hosogai N; Tahara A; Kurama T; Shimokawa T; Aramori I
Br J Pharmacol; 2009 Oct; 158(3):879-87. PubMed ID: 19694723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
